Patent · US Active

Heterocyclic compounds and uses thereof

US8785470B2 · kind B2 · utility

38Cited by

172References

24Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Alfredo C. Castro · Woburn, US
Catherine A. Evans · Somerville, US
Somarajannair Janardanannair · Woburn, US
Andre Lescarbeau · Somerville, US
Tao Liu · Shanghai, CN
Daniel A. Snyder · Somerville, US
Martin Tremblay · Waltham, US
Pingda Ren · San Diego, US
Yi Liu · San Diego, US
Liansheng Li · San Diego, US
Katrina Chan · Fremont, US

Key dates

Filing date	Jul 18, 2012
Grant date	Jul 22, 2014
Priority date	—
Expiry date	Jul 18, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.